Lv1
40 积分 2024-05-27 加入
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
1个月前
已完结
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
1个月前
已完结
[Consensus on the clinical use of CDK4/6 inhibitors for the treatment of hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer (2023 edition)]
1个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
1个月前
已完结
PARP Inhibitors for Breast Cancer Treatment
2个月前
已完结
AZD5305 More Tolerable than Earlier PARP Agents
3个月前
已完结
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
3个月前
已完结
Olaparib for Metastatic Castration-Resistant Prostate Cancer
3个月前
已完结
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
3个月前
已完结
The impact of liver resection on survival for patients with metastatic breast cancer – A systematic review and meta-analysis
6个月前
已采纳
Effect of energy distribution on laser cleaning quality of 30Cr3 ultra-high strength steel
6个月前
已采纳
A new system for the production and storage of thermal energy based on two complementary and different types of phase changing materials
6个月前
已采纳
Novel strategies for targeting neutrophil against myocardial infarction
6个月前
已采纳
皖公网安备34019202002308
